Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence—I

por Wei, Dongqing, Peslherbe, Gilles H., Selvaraj, Gurudeeban, Wang, Yanjing
Publicado 2022

Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches

por Selvaraj, Gurudeeban, Kaliamurthi, Satyavani, Peslherbe, Gilles H., Wei, Dong-Qing
Publicado 2021

Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights

por Selvaraj, Gurudeeban, Kaliamurthi, Satyavani, Peslherbe, Gilles H., Wei, Dong-Qing
Publicado 2021

Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19

por Kaliamurthi, Satyavani, Selvaraj, Gurudeeban, Selvaraj, Chandrabose, Singh, Sanjeev Kumar, Wei, Dong-Qing, Peslherbe, Gilles H.
Publicado 2021

Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis

por Huang, Siyuan, Wei, Yong-Kai, Kaliamurthi, Satyavani, Cao, Yanghui, Nangraj, Asma Sindhoo, Sui, Xin, Chu, Dan, Wang, Huan, Wei, Dong-Qing, Peslherbe, Gilles H., Selvaraj, Gurudeeban, Shi, Jiang
Publicado 2020